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comprising brain microvascular endothelial cells (BMEC), astrocyte 
and pericyte by taking advantage of immortalized cell line utility that 
allows various experimental approaches.
Methods: A human BBB model was constructed using immortalized 
human BMEC (HBMEC/ci18), astrocyte (HASTR/ci35), pericyte (HPBC/
ci37). The gene expressions were determined by qPCR and immuno-
cytochemistry. The BBB functions were examined by determining 
transendothelial electric resistance (TEER), lucifer yellow (LY) permea-
bility and P-glycoprotein (P-gp) bi-directional transport. In the perme-
ability assay, compounds were quantified by LC–MS/MS system.
Results: HBMEC/ci18 co-cultured with HASTR/ci35 and HBPC/ci37 
showed elevated TEER (2.0-fold), reduced LY permeability (0.7-fold) 
and increased P-gp function (1.4-fold) compared with mono-culture. 
In support of these findings, expression levels of multiple BBB-specific 
genes, including barrier formation, transporters and receptors, were 
increased as well as their typical cellular localization in co-culture 
model. Notably, we performed BBB permeability assays using a set of 9 
compounds with known CNS permeability characteristics. Expectedly, 
CNS-positive compounds (memantine, diphenhydramine, proprano-
lol and pyrilamine) displayed high permeability coefficient values (Pe) 
(522 ± 100 to 1398 ± 324 × 10−6 cm/s). In contrast, CNS-negative com-
pounds (quinidine, desloratadine, rhodamine 123, LY, sodium fluores-
cein) showed low Pe (21 ± 11 to 161 ± 31 × 10−6 cm/s).
Conclusion: We successfully developed a functional and scalable 
human BBB model. We hope that such research efforts are likely to 
open up new possibility of quantitative prediction of human CNS 
action based on in vitro experiment.
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Objective: Biological barriers-on-a-chip models are cutting edge micro-
engineered devices, but only a few combine the crucial parameters to 
study transport mechanisms, drug delivery and pathologies. Our labo-
ratory developed a microelectric device (Walter et al. 2016), which ena-
bles visual observation, transendothelial electrical resistance (TEER) and 
permeability measurements on several biological barriers. The objective 
of our study was to further improve the device to make it more user-
friendly and add novel functions.
Methods: The device was built up from a porous cell culture membrane 
sandwiched between two layers of PDMS and a top and bottom plastic 
slide coated with gold electrodes. After an automatic feeding period 
when the cells became confluent, a peristaltic pump was used to circu-
late the cell culture medium to mimic the blood flow. To verify the integ-
rity, TEER was assessed with custom electrodes connected to an EVOM2 
device. The endothelial surface charge was measured using silver elec-
trodes connected to the outlets of the device. To validate our biochip we 
cultured the hCMEC/D3 human brain endothelial cell line and the stem 
cell derived CD34+ human endothelial cells in co-culture with bovine 
pericytes.
Results: We improved and optimized the biochip by (i) redesigning the 
shape of the electrodes, (ii) using universal luer-outlets, (iii) introducing 
small screws around the edges of the biochip we eliminated the use of 
the adhesive glue and (iv) could disassemble and reuse the device. The 
resistance was measured in real time using a custom made application 
compatible with cell phones. In the biochip under flow conditions the 
TEER elevated significantly in both BBB models which was also con-
firmed by ZO-1 and β-catenin immunostainings. A gene expression 
study was performed to investigate the differences between static and 
dynamic conditions on brain endothelial cells. Moreover a novel meas-
urement of surface potential was also introduced.
Conclusion: This novel in vitro device for BBB culture models provides 
users with a standardized, reliable and reusable platform to perform 
pathology and pharmacology experiments. With advancement of the 
electrode layout, TEER automation and surface potential measurement 
our device is a cutting edge invention in the barrier-chip field.
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Objectives: Strong interdependence between severity of microcir-
culation impairment and time-based perfusion parameters has been 
recently reported. In particular, mean transit time (MTT) appears to 
show good association with cerebral small vessel disease (1, 2). Blood 
brain barrier (BBB) damage, in turn, is considered as a main initial path-
ogenic mechanism in cerebral small vessel disease (3, 4).
We tested the hypothesis that absolute computed tomography 
(CT) markers of BBB and cerebral microcirculation would improve 
36 months after internal carotid artery stenting for symptomatic 
carotid stenosis while results obtained 6–8 weeks after stenting proce-
dure would yield predictive value.
Methods: We recruited consecutive eligible patients with > 70% 
symptomatic single carotid stenosis with a complete circle of Wil-
lis and normal vertebral arteries to observational cohort study. We 
detected changes in cerebral blood flow (CBF), cerebral blood volume 
(CBV), MTT, time to peak (TTP) and permeability surface area-product 
(CT marker of BBB permeability, PS) before and after carotid stenting. 
We compared absolute differences in ipsilateral and contralateral CT 
perfusion markers before and after stenting. The search for regression 
models of “36 months after stenting” results were based on stepwise 
analysis with bidirectional elimination method.
Results: A total of 34 patients completed 36 months follow-up (15 
females, mean age of 69.68 ± SD 7.61 years). At 36 months after stent-
ing, absolute values for CT perfusion markers had improved: CBF 
(ipsilateral: + 7.76%, contralateral: + 0.95%); CBV (ipsilateral: + 5.13%, 
contralateral: + 3.00%); MTT (ipsilateral: − 12.90%; contralateral: 
− 5.63%); TTP (ipsilateral: − 2.10%, contralateral: − 4.73%) and PS 
(ipsilateral: − 35.21%, contralateral: − 35.45%). MTT and PS assessed 
6–8 weeks after stenting predicted the MTT (ipsilateral: R2 = 0.867, 
contralateral R2 = 0.688) and PS (R2 = 0.314 for ipsilateral side and 
R2 = 0.394) value 36 months after stenting.
Conclusions: Improvements in BBB permeability and cerebral micro-
circulation persist for at least 3 years after carotid artery stenting in 
symptomatic patients. MTT and PS measured 6–8 weeks after stenting 
provides predictive value with respect to MTT and PS 36 months after 
stenting. Diminished PS values may suggest a decline in overall oxida-
tive and inflammatory status.
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